Will Stone
👤 SpeakerAppearances Over Time
Podcast Appearances
Kennedy made the comments about a month ago on Joe Rogan's podcast.
He said to expect an announcement on about 14 of these peptides in a few weeks.
The peptides in question are big in the world of biohacking and longevity, used for immune function, skin health, tissue repair, and more.
Scott Bruner with the Alliance for Pharmacy Compounding hopes Kennedy makes the changes, but says it will take time for the supply to be available.
They're going to have prescribers and patients dashing to their compounding pharmacy only to be frustrated.
A sketchy market for peptides has flourished under the FDA restrictions, but researchers also warn there is very little human clinical data on safety and efficacy of these therapies, which haven't been approved by the FDA.
The study enrolled just over 80 current smokers who were randomly separated into two groups.
The other ingested a relatively high dose of pure psilocybin just one time.
At the six-month mark, the psilocybin group had more than six times greater odds of being abstinent from cigarettes than their counterparts who had nicotine.
Matthew Johnson at Johns Hopkins led the study.
Everyone in the trial also underwent 13 weeks of cognitive behavioral therapy.
Recent interest in psychedelics has mostly focused on depression and other mental health conditions.
Psilocybin could be considered for drug approval in the next few years.
The study enrolled just over 80 current smokers who were randomly separated into two groups.
The other ingested a relatively high dose of pure psilocybin just one time.
At the six-month mark, the psilocybin group had more than six times greater odds of being abstinent from cigarettes than their counterparts who had nicotine.
Matthew Johnson at Johns Hopkins led the study.